Physician profile
Daniel S Hoffman
NPI 1881823227
$40,432.69
in general payments reported to CMS, 2019-2025
33 companies · $2,159 in 2025
The $2,159 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,182 · 2020: $5,524 · 2021: $12K · 2022: $8,859 · 2023: $2,179 · 2024: $1,726 · 2025: $2,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,855 · Travel and Lodging: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,855.06 |
| Travel and Lodging | $209.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $13,463.35 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $11,013.59 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $3,588.06 | 2019-2025 | Axonics, General - Therapies |
| Teleflex LLC | $3,132.70 | 2021-2025 | Urolift, Barrigel |
| Medtronic USA, INC. | $2,106.47 | 2019-2020 | |
| Medtronic, INC. | $1,962.24 | 2021-2023 | Interstim |
| Coloplast Corp | $1,239.27 | 2019-2025 | Altis |
| Calyxo, INC. | $761.10 | 2024-2025 | Cvac Aspiration System |
| Bluewind Medical | $711.39 | 2024-2025 | Revi |
| Neotract INC. | $264.87 | 2019-2020 | |
| Dentsply Ih Ab | $247.55 | 2023-2025 | Lofric, Lofric |
| Sumitomo Pharma America, INC. | $228.65 | 2023 | Gemtesa, Orgovyx |
| Astellas Pharma Global Development | $203.50 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $167.15 | 2020-2023 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $159.63 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $149.08 | 2020-2023 | |
| Urogen Pharma, INC. | $143.86 | 2022 | |
| Allergan, INC. | $142.80 | 2020-2021 | |
| Urovant Sciences INC | $139.89 | 2022 | |
| Baxter Healthcare | $123.00 | 2023 | Floseal |
| Karl Storz Endoscopy-America | $97.77 | 2021 | |
| Janssen Biotech, INC. | $69.93 | 2022-2023 | Erleada |
| Abbvie INC. | $68.85 | 2023 | |
| Lumenis, INC | $37.29 | 2021 | |
| 180 Medical, INC. | $29.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.89 | 2023 | |
| Smith+Nephew, INC. | $28.00 | 2024 | Stravix |
| Guard Medical INC. | $23.15 | 2025 | Npseal |
| Myriad Genetic Laboratories, INC. | $22.64 | 2022 | |
| Myovant Sciences INC. | $22.18 | 2022 | |
| Olympus America INC. | $20.65 | 2023 | Itind System |
| Convatec INC. | $17.98 | 2023 | |
| Blue Earth Diagnostics | $17.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.